Hospital Roger Salengro

Lille 59000

0 studies enrolling now · 4 studies all time

What they study most

Multiple Sclerosis, Relapsing-Remitting, Narcolepsy, Obstructive Sleep Apnea

Studies at this site

• "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy" — Completed
• "Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" — Completed
• "A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA" — Completed
• Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two — Completed